Product Information

COMBIVENT RESPIMAT 20-100 MCG is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $124.1401 per GM under NDC 00597002402. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Oct 7, 2011.

COMBIVENT RESPIMAT 20-100 MCG

ipratropium bromide and albuterol
$124.1401per GM

Strength

100; 20 ug/1; ug/1

NDC

00597002402

Classification

Brand

Dosage Form

SPRAY, METERED

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021747

FDA Approved

10/7/2011

On Market Since

7/1/2012

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for COMBIVENT RESPIMAT 20-100 MCG has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 93.2%. The table below summarizes its recorded NADAC range and movement.

Current price$124.1401 per GM
All-time high$124.2865 (May 13, 2026)
All-time low$63.8516 (May 21, 2014)
52-week high$124.2865
52-week low$120.6438
Median price$102.2117
Average price$97.0082
Largest weekly change+8.0% (Apr 13, 2016)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

+2.9%

3Y

+9.0%

5Y

+16.8%

All

+93.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ipratropium bromide and albuterol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of COMBIVENT RESPIMAT 20-100 MCG?

The current National Average Drug Acquisition Cost (NADAC) for COMBIVENT RESPIMAT 20-100 MCG, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $124.1401 per GM (NDC 00597002402), effective Aug 19, 2026.

How has the price of COMBIVENT RESPIMAT 20-100 MCG changed over time?

Over the history we have for it, the NADAC for COMBIVENT RESPIMAT 20-100 MCG has risen 93.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for COMBIVENT RESPIMAT 20-100 MCG?

Since Nov 28, 2013, the NADAC for COMBIVENT RESPIMAT 20-100 MCG has ranged from a low of $63.8516 (May 21, 2014) to a high of $124.2865 (May 13, 2026), with a median of $102.2117 per GM.

Are there cheaper alternatives to COMBIVENT RESPIMAT 20-100 MCG?

No other NADAC-published product currently shares the active ingredient and strength of COMBIVENT RESPIMAT 20-100 MCG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures COMBIVENT RESPIMAT 20-100 MCG?

COMBIVENT RESPIMAT 20-100 MCG (NDC 00597002402) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.